Emgality and Lower limb fracture - a phase IV clinical study of FDA data

Summary:

Lower limb fracture is reported as a side effect among people who take Emgality (galcanezumab-gnlm), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Sumatriptan, and have Migraine.

The phase IV clinical study analyzes which people have Lower limb fracture when taking Emgality. It is created by eHealthMe based on reports of 24,623 people who have side effects when taking Emgality from the FDA, and is updated regularly.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

What is Lower limb fracture?

Lower limb fracture is found to be associated with 1,004 drugs and 889 conditions by eHealthMe. Check the latest studies of Lower limb fracture.

On Jul, 29, 2026

24,623 people reported to have side effects when taking Emgality.
Among them, 16 people (0.06%) have Lower limb fracture.

$Could Emgality cause Lower limb fracture?$

Among these 16 people:

How long have people been on Emgality when they have Lower limb fracture? *

What is the gender of people who have Lower limb fracture when taking Emgality? *

female: 100 %
male: 0.0 %

What is the age of people who have Lower limb fracture when taking Emgality? *

What are other drugs people take besides Emgality? *

Acetaminophen: 5 people, 31.25%
Ibuprofen: 5 people, 31.25%
Sumatriptan: 5 people, 31.25%
Fioricet: 4 people, 25.00%
Dulera: 4 people, 25.00%
Eliquis: 4 people, 25.00%
Epinephrine: 4 people, 25.00%
Famotidine: 4 people, 25.00%
Fenofibrate: 4 people, 25.00%
Fludrocortisone Acetate: 4 people, 25.00%

What are other side effects people have besides Lower limb fracture? *

Injection Site Warmth: 4 people, 25.00%
Post Procedural Discharge: 4 people, 25.00%
Infusion Site Haemorrhage (bleeding from infusion site): 4 people, 25.00%
Infusion Site Pain: 4 people, 25.00%
Infusion Site Pruritus (severe itching at infusion site): 4 people, 25.00%
Infusion Site Swelling: 4 people, 25.00%
Infusion Related Reaction: 4 people, 25.00%
Infection: 4 people, 25.00%
Kidney Stones: 4 people, 25.00%
Impaired Gastric Emptying: 4 people, 25.00%

What are the existing conditions these people have? *

Migraine (headache): 5 people, 31.25%
Immunodeficiency Common Variable: 4 people, 25.00%
Headache (pain in head): 1 person, 6.25%
Cluster Headache (one-sided head pain with tearing): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Emgality and have Lower limb fracture?

- Check whether Lower limb fracture is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emgality:

Emgality (24,702 reports)

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lower limb fracture:

Lower limb fracture (1,004 drugs)

Browse all the conditions that are associated with Lower limb fracture:

Lower limb fracture (889 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on galcanezumab-gnlm (the active ingredients of Emgality) and Emgality (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.